The Soy Isoflavones for Reducing Bone Loss (SIRBL) Study: a 3-y randomized controlled trial in postmenopausal women1234
Cited by (0)
- 1
From the Nutrition and Wellness Research Center, Department of Food Science and Human Nutrition (DLA, LNH, JWS, and KBH) and the Department of Statistics (KJK and CTP), Iowa State University, Ames, IA; the US Department of Agriculture, Agricultural Research Service, Western Human Nutrition Research Center, University of California, Davis, CA (MDVL); and the Department of Food Science and Nutrition, University of Minnesota, St Paul, MN (MSK).
- 2
The content and views expressed in this article are the sole responsibility of the authors and do not necessarily represent the official views of the funding agencies. Funding agencies did not play a role in data collection, management, analysis, or interpretation, or in manuscript preparation or review.
- 3
Supported mainly by a grant (RO1 AR046922) from the National Institute of Arthritis and Musculoskeletal and Skin Diseases; also supported by the Nutrition and Wellness Research Center, Iowa State University; USDA/ARS, Western Human Nutrition Research Center, Clinical and Translational Science Center, Clinical Research Center, University of California (1M01RR19975-01); and National Center for Medical Research (UL1 RR024146). Archer Daniels Midland Company (Decatur, IL) donated soy isoflavone tablets (Novasoy), and GlaxoSmithKline (Moon Township, PA) donated calcium and vitamin D supplements (Os-Cal).
- 4
Address correspondence to DL Alekel, Nutrition and Wellness Research Center, Iowa State University, Research Park, Building 6, 2325 North Loop Drive, Suite 6100, Ames, IA 50010-8281. E-mail: [email protected].